VMP 27624211000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules
BNF code 0905013G0AADBDB
Virtual Therapeutic Moiety Magnesium glycerophosphate
Abbreviated name Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) caps
Basis of preferred name Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Magnesium glycerophosphate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 72717003
Strength value numerator 39.500
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsule.oral
Dose Form
Formulation Oral capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd)
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules (Special Order)
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd)
Virtual Medicinal Product Packs
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 1 capsule
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.

Feedback